Epiomic Epidemiology Series: Addison’s Disease Forecast in 10 Major Markets 2016-2026

Date: 2016-03

“Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Addison’s Disease in 10 Major Markets
Addison’s disease (AD) is a chronic and rare endocrinal disorder, caused by destruction of the adrenal cortex which leads to the reduced production of glucocorticoids, mineralocorticoids and adrenal androgens. Chronic adrenal insufficiency and hypersecretion of ACTH is representative of the basic clinical signs and symptoms. AD can be part of the autoimmune polyglandular syndrome (PAS) (type 1 and 2), or it may present as an isolated disorder.
This report provides the current prevalent population for Addison’s disease across 10 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, and Poland) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Addison’s have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for Addison’s disease include:
• Autoimmune Thyroiditis (AT)
• Type 1 diabetes (T1D)
• Anaemia
• Vitiligo
• Chronic Fatigue
• Premature Ovarian Failure
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Reason to buy
• Able to quantify patient populations in global Addison’s disease’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the prevalence of the subdivided types of Addison’s disease and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on Addison’s disease’s prevalent population.
• Identify sub-populations within Addison’s disease which require treatment.
• Gain an understanding of the specific markets that have the largest number of Addison’s disease patients.


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample